Efectos citotoxicos in vitro de extractos y fracciones de Espeletia killipii Cuatr. frente a lineas celulares tumorales humanos / Efeitos citotóxicos in vitro de extratos e frações de Espeletia killipii Cuatr. frente a linhas celulares tumorais humanas / In vitro cytotoxic effects of extract and fractions of Espeletia killipii Cuatr. against human tumor cell lines

RESUMO

O extrato etanólico e as frações de Espeletia killipii (espécie endêmica da vegetação dos páramos do altiplano Cundiboyacense); mostraram atividade citotóxica significativa in vitro nas linhagens celulares tumorais humanas de câncer de mama MCF-7, CSC-1170, CSC-1595, CSC-3322, CSC-3325 e na linhagem Hep-2 de laringe. A fração CH2Cl2 e suas sub-frações foram ativas contra as linhagens celulares cancerígenas de mama na concentração de 50 µg/mL, obtendo-se percentagens de viabilidade entre 13 e 20 por cento. O principio ativo ainda não identificado foi obtido por ensaios bioguiados sucessivos e apresentou valores de Concentração Citotóxica media (CC50) menores que 1 µg/mL para as linhagens celulares colombianas CSC-1170, CSC-1595, CSC-3322 e CSC-3325; CC50 = 1 µg/mL contra MDA MB 435 e NCl-H23; contra MCF-7 uma CC50 = 2 µg/mL e uma CC50 superior a 16 µg/mL contra PC-3 e U-251.

ABSTRACT

It was found that the ethanol extracts and fractions of Espeletia killipii (an endemic species of the páramo vegetation of the Cundiboyacense plateau) exhibited cytotoxic activity against several human tumor cell lines. Thus, the extracts and fractions exhibited significant cytotoxic activity against both the human tumor cell lines of breast cancer MCF-7, CSC-1170, CSC-1595, CSC-3322, CSC-3325 and the Hep-2 cell lines of laryns. The CH2Cl2 fraction and its sub-fractions were active against the breast lines at concentration of 50 µg/mL, with a viability percentage between 13 and 20 percent. The active principle, not identified yet, was obtained by successive bio-directed assays. It showed activity against the Colombian cell lines CSC-1170, CSC-1595, CSC-3322 and CSC-3325 at a half Cytotoxic Concentration (CC50) less than 1 µg/mL, against MDA MB-435 and NCI-H23 at CC50= 1 µg/mL against MCF-7 at CC50= 2 µg/mL, and against PC-3 and U-251 at CC50 greater than 16 µg/mL.